• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

它有效且安全吗?父母对特应性皮炎药物依从性的看法。

Does it work and is it safe? Parents' perspectives on adherence to medication for atopic dermatitis.

作者信息

Capozza Korey, Schwartz Alan

机构信息

Global Parents for Eczema Research, Los Angeles, California.

Department of Medical Education and Department of Pediatrics, University of Illinois Chicago, Chicago, Illinois.

出版信息

Pediatr Dermatol. 2020 Jan;37(1):58-61. doi: 10.1111/pde.13991. Epub 2019 Aug 28.

DOI:10.1111/pde.13991
PMID:31464037
Abstract

BACKGROUND

Though adherence is low among caregivers of children with atopic dermatitis (AD), the reasons for it are poorly understood. This study aims to assess the self-reported prevalence of non-adherence and reasons for changing prescription regimens among parents of children with AD.

METHODS

A link to a 15-question online survey was posted to social media sites engaging parents of children with eczema, worldwide. Items included a scale related to physician trust. Results were analyzed using R 3.4 and summarized using normal and nonparametric descriptive statistics as appropriate for each item.

RESULTS

Eighty-six eligible parents responded to the survey and provided information about medication adherence. The mean age of respondents' children was 6.2 years (SD 4.4 years), and the majority were children with moderate or severe eczema (40.5% moderate and 42.9% severe). Just over half (54.7%) reported taking or applying eczema medications as directed by their physician. Of those that did not, 30.2% took or applied less medications, and 12.8% stopped taking or applying medications altogether. The top reasons for deviating from directions were as follows: (a) worry about side effects, (b) symptom resolution, and (c) perception that the medication was not working. Trust toward physician was significantly associated with taking medication as directed.

CONCLUSIONS

Decisions about adherence to medications are made in the context of perceived benefits versus anticipated side effects. Findings highlight opportunities for improving adherence, and thereby improving outcomes for children with moderate-severe AD.

摘要

背景

尽管特应性皮炎(AD)患儿的 caregivers 依从性较低,但其原因尚不清楚。本研究旨在评估 AD 患儿家长自我报告的不依从患病率以及改变处方治疗方案的原因。

方法

在全球范围内,向参与湿疹患儿家长的社交媒体网站发布了一份包含 15 个问题的在线调查问卷链接。项目包括与医生信任相关的量表。使用 R 3.4 对结果进行分析,并根据每个项目的情况使用正态和非参数描述性统计进行总结。

结果

86 名符合条件的家长回复了调查问卷,并提供了关于药物依从性的信息。受访者孩子的平均年龄为 6.2 岁(标准差 4.4 岁),大多数是中度或重度湿疹患儿(40.5%为中度,42.9%为重度)。略超过一半(54.7%)的家长报告按照医生的指示服用或涂抹湿疹药物。在未按指示服药的家长中,30.2%服用或涂抹的药物较少,12.8%完全停止服用或涂抹药物。偏离指示的主要原因如下:(a)担心副作用,(b)症状缓解,以及(c)认为药物无效。对医生的信任与按指示服药显著相关。

结论

关于药物依从性的决定是在感知到的益处与预期的副作用的背景下做出的。研究结果突出了改善依从性的机会,从而改善中度至重度 AD 患儿的治疗效果。

相似文献

1
Does it work and is it safe? Parents' perspectives on adherence to medication for atopic dermatitis.它有效且安全吗?父母对特应性皮炎药物依从性的看法。
Pediatr Dermatol. 2020 Jan;37(1):58-61. doi: 10.1111/pde.13991. Epub 2019 Aug 28.
2
Adherence in Atopic Dermatitis.特应性皮炎的依从性。
Adv Exp Med Biol. 2017;1027:139-159. doi: 10.1007/978-3-319-64804-0_12.
3
Caregiver willingness to treat atopic dermatitis is not much improved by anchoring.照护者治疗特应性皮炎的意愿通过锚定并未得到很大改善。
J Dermatolog Treat. 2019 Aug;30(5):471-474. doi: 10.1080/09546634.2018.1530442. Epub 2018 Dec 3.
4
Adherence in Atopic Dermatitis.特应性皮炎的依从性。
Adv Exp Med Biol. 2024;1447:169-190. doi: 10.1007/978-3-031-54513-9_15.
5
Characterization of socioeconomic status of Japanese patients with atopic dermatitis showing poor medical adherence and reasons for drug discontinuation.日本特应性皮炎患者医疗依从性差的社会经济状况特征及停药原因
J Dermatol Sci. 2015 Sep;79(3):279-87. doi: 10.1016/j.jdermsci.2015.05.010. Epub 2015 Jun 16.
6
Optimizing pharmaceutical care for pediatric patients with dermatitis: perspectives of parents and pharmacy staff.优化皮肤科患儿的药学服务:家长和药剂师的观点。
Int J Clin Pharm. 2019 Jun;41(3):711-718. doi: 10.1007/s11096-019-00827-1. Epub 2019 Apr 24.
7
Topical Corticosteroid Concerns Among Parents of Children with Psoriasis versus Atopic Dermatitis: A French Multicenter Cross-Sectional Study.儿童银屑病与特应性皮炎患儿家长的局部皮质类固醇担忧:法国多中心横断面研究。
Am J Clin Dermatol. 2018 Apr;19(2):261-265. doi: 10.1007/s40257-017-0318-5.
8
Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers.患有特应性皮炎幼儿的父母及其医疗服务提供者中的皮质类固醇恐惧症(皮质激素恐惧症)
Pediatr Dermatol. 2019 Jan;36(1):100-104. doi: 10.1111/pde.13698. Epub 2018 Oct 18.
9
Topical corticosteroid phobia among parents of children with atopic dermatitis in a semirural area of Norway.挪威半农村地区特应性皮炎患儿家长对局部用皮质类固醇激素的恐惧
J Eur Acad Dermatol Venereol. 2016 Jan;30(1):168. doi: 10.1111/jdv.12670. Epub 2014 Aug 29.
10
TOPICOP©: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents.TOPICOP©:一种评估特应性皮炎门诊患者及其父母对外用皮质类固醇恐惧的新量表。
PLoS One. 2013 Oct 16;8(10):e76493. doi: 10.1371/journal.pone.0076493. eCollection 2013.

引用本文的文献

1
A pharmacovigilance analysis of abrocitinib-related skin adverse events based on the FDA Adverse Event Reporting System (FAERS).基于美国食品药品监督管理局不良事件报告系统(FAERS)的阿巴西普相关皮肤不良事件的药物警戒分析。
Arch Dermatol Res. 2025 Feb 15;317(1):419. doi: 10.1007/s00403-025-03959-9.
2
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials.0.15%罗氟司特乳膏用于成人和儿童特应性皮炎:INTEGUMENT-1和INTEGUMENT-2随机临床试验
JAMA Dermatol. 2024 Nov 1;160(11):1161-1170. doi: 10.1001/jamadermatol.2024.3121.
3
Educational and psychological interventions for managing atopic dermatitis (eczema).
管理特应性皮炎(湿疹)的教育和心理干预措施。
Cochrane Database Syst Rev. 2024 Aug 12;8(8):CD014932. doi: 10.1002/14651858.CD014932.pub2.
4
Parental Attitudes and Practices regarding Atopic Dermatitis: A Cross-Sectional Study among a Thai Population.泰国人群中关于特应性皮炎的父母态度与行为:一项横断面研究
Children (Basel). 2024 Jul 18;11(7):870. doi: 10.3390/children11070870.
5
Comparison of lotions, creams, gels and ointments for the treatment of childhood eczema: the BEE RCT.洗剂、乳膏、凝胶和软膏治疗儿童湿疹的比较:BEE RCT。
Health Technol Assess. 2023 Oct;27(19):1-120. doi: 10.3310/GZQW6681.
6
How and what adverse events are reported and captured in randomized control trials of emollients in the treatment of eczema?在治疗湿疹的保湿剂随机对照试验中,是如何报告和捕捉不良反应事件的?
Clin Exp Dermatol. 2023 Jul 21;48(8):889-894. doi: 10.1093/ced/llad137.
7
Antibiotic perceptions, adherence, and disposal practices among parents of pediatric patients.儿科患者家长对抗生素的认知、使用依从性和处置行为。
PLoS One. 2023 Feb 9;18(2):e0281660. doi: 10.1371/journal.pone.0281660. eCollection 2023.
8
A low level of health literacy is a predictor of corticophobia in atopic dermatitis.健康素养水平低是特应性皮炎患者皮质恐惧症的预测指标。
An Bras Dermatol. 2022 Nov-Dec;97(6):704-709. doi: 10.1016/j.abd.2021.11.007. Epub 2022 Aug 31.
9
Refractory Pediatric Psoriasis and Atopic Dermatitis: The Importance of Therapeutical Adherence and Biological Management.难治性儿童银屑病和特应性皮炎:治疗依从性和生物治疗管理的重要性。
Biomedicines. 2021 Aug 4;9(8):958. doi: 10.3390/biomedicines9080958.
10
Children's Views and Experiences of Treatment Adherence and Parent/Child Co-Management in Eczema: A Qualitative Study.儿童对湿疹治疗依从性及亲子共同管理的看法和体验:一项定性研究
Children (Basel). 2021 Feb 20;8(2):158. doi: 10.3390/children8020158.